Sunshine Biopharma (SBFMW) Gross Margin Growth (3y) (2021 - 2026)

Sunshine Biopharma (SBFMW) Gross Margin Growth (3y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Teva Pharmaceutical Industries 39.97 Bn 36.23 Bn 1.97 Bn 631.00
2 Zoetis 33.59 Bn 31.65 Bn 1.62 Bn 106.00
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -675.00
4 Neurocrine Biosciences 16.10 Bn 14.78 Bn 800.70 Mn 33.00
5 Aurora Cannabis 15.56 Bn 15.47 Bn 21.72 Mn -
6 Elanco Animal Health 12.04 Bn 11.61 Bn 785.00 Mn -344.00
7 Alkermes 7.36 Bn 6.84 Bn -116.06 Mn -37,361.00
8 Lantheus Holdings 6.74 Bn 6.24 Bn 230.92 Mn 3,557.00
9 Liquidia 6.27 Bn 6.04 Bn 121.79 Mn 622.00
10 Sunshine Biopharma - - 2.18 Mn -1,039.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -1,039.00
Dec 31, 2025 -253.00
Sep 30, 2025 -1,783.00
Jun 30, 2025 -1,394.00
Mar 31, 2025 -2,053.00
Dec 31, 2024 424.00
Sep 30, 2024 -2,730.00
Jun 30, 2024 -3,966.00
Mar 31, 2024 -2,255.00
Dec 31, 2023 -2,921.00
Sep 30, 2023 -2,963.00
Jun 30, 2023 -3,081.00
Mar 31, 2023 -2,767.00
Dec 31, 2022 -2,251.00
Sep 30, 2022 2,272.00
Jun 30, 2022 -155.00
Mar 31, 2022 557.00
Mar 31, 2021 6,435.00